Soluble interleukin 2 receptor in atopic eczema.

Graham Colver, Julian Symons, Gordon W. Duff

BMJ · 1989 · 75 citations · 28 references

DOIFull text

Open access

Abstract

Cellular immunopathogenic mechanisms contribute to atopic eczema. Immune activation can be measured in atopic eczema by measurements of soluble interleukin 2 receptor, and this should facilitate assessment of response to treatment.

References

28